Zeev Weiss
Corporate Officer/Principal presso APREA THERAPEUTICS, INC.
Profilo
Zeev Weiss is currently the Chief Business Advisor at Aprea Therapeutics, Inc. and the President of WeedOUT Ltd.
Previously, he served as the Chief Executive Officer & Director at Intec Pharma Ltd.
from 2015 to 2017.
He also held the position of Head-Life Sciences Strategic Consulting at PricewaterhouseCoopers (Israel) from 2002 to 2006.
Additionally, Mr. Weiss was the Chief Business Officer at Atrin Pharmaceuticals, Inc. from 2018 to 2022.
He obtained his undergraduate and graduate degrees from Tel-Aviv University.
Posizioni attive di Zeev Weiss
| Società | Posizione | Inizio |
|---|---|---|
| APREA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2022 |
WeedOUT Ltd.
 WeedOUT Ltd. Chemicals: AgriculturalProcess Industries WeedOUT Ltd. is an Israeli company that focuses on exploiting sterility against resistant weeds. The company is based in Ness Ziona, Israel. Orly Noivirt-Brik, Efrat Lidor Nili has been the CEOs since 2016. The company was founded in 2016 by Orly Noivirt-Brik, Efrat Lidor Nili. | Presidente | - |
Precedenti posizioni note di Zeev Weiss
| Società | Posizione | Fine |
|---|---|---|
Atrin Pharmaceuticals, Inc.
 Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Corporate Officer/Principal | 01/05/2022 |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Amministratore Delegato | 04/05/2017 |
PricewaterhouseCoopers (Israel)
 PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Israel) provides legal services. The company is based in Tel Aviv, Israel. | Corporate Officer/Principal | 01/09/2006 |
Formazione di Zeev Weiss
| Tel-Aviv University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APREA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
WeedOUT Ltd.
WeedOUT Ltd. Chemicals: AgriculturalProcess Industries WeedOUT Ltd. is an Israeli company that focuses on exploiting sterility against resistant weeds. The company is based in Ness Ziona, Israel. Orly Noivirt-Brik, Efrat Lidor Nili has been the CEOs since 2016. The company was founded in 2016 by Orly Noivirt-Brik, Efrat Lidor Nili. | Process Industries |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Health Technology |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Israel) provides legal services. The company is based in Tel Aviv, Israel. | Commercial Services |
- Borsa valori
- Insiders
- Zeev Weiss
